Why Target Aging?

The world population is aging rapidly, creating a growing public health and economic burden. Aging is the common denominator behind most chronic diseases — from cancer to Alzheimer’s.

Without addressing the root cause — biological aging — treating one disease only delays the onset of another. By extending healthspan, we can reduce disease burden, improve quality of life, and boost economic value across society.

Our Approach

Biological aging drives the decline of cellular function, leading to disease. Targeting its root mechanisms opens new doors for longevity.

Our technology resets cellular aging markers, enabling safe, scalable and cost-effective rejuvenation. We developed the first chemical reprogramming approach to reverse aging — not just delay it — and go beyond traditional drug development by addressing all aging pathways at once.

With a strong scientific foundation, biotech business expertise, and a clear roadmap, we are pioneering a new class of reprogramming therapeutics to target aging at its root.